Tonix Pharmaceuticals Holding Corp (TNXP)
0.1925
+0.01
(+4.90%)
USD |
NASDAQ |
May 06, 10:16
Tonix Pharmaceuticals Cash from Investing (Quarterly): -0.431M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.431M |
| September 30, 2023 | -0.821M |
| June 30, 2023 | -24.02M |
| March 31, 2023 | -3.799M |
| December 31, 2022 | -4.671M |
| September 30, 2022 | -8.82M |
| June 30, 2022 | -14.44M |
| March 31, 2022 | -20.22M |
| December 31, 2021 | -25.62M |
| September 30, 2021 | -7.751M |
| June 30, 2021 | -1.429M |
| March 31, 2021 | -0.505M |
| December 31, 2020 | -4.534M |
| September 30, 2020 | -4.016M |
| June 30, 2020 | -0.014M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.005M |
| September 30, 2019 | -0.002M |
| June 30, 2019 | -0.003M |
| March 31, 2019 | -0.007M |
| December 31, 2018 | 0.001M |
| September 30, 2018 | -0.003M |
| June 30, 2018 | -0.002M |
| March 31, 2018 | -0.002M |
| December 31, 2017 | -0.003M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 2.478M |
| March 31, 2017 | 4.694M |
| December 31, 2016 | 3.856M |
| September 30, 2016 | 5.241M |
| June 30, 2016 | 2.734M |
| March 31, 2016 | 4.718M |
| December 31, 2015 | -1.925M |
| September 30, 2015 | -22.09M |
| June 30, 2015 | -0.153M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | -0.125M |
| September 30, 2014 | -0.16M |
| June 30, 2014 | -0.105M |
| March 31, 2014 | -0.002M |
| December 31, 2013 | -0.007M |
| September 30, 2013 | -0.008M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.0003M |
| September 30, 2012 | -0.0019M |
| June 30, 2012 | -0.0338M |
| March 31, 2012 | -0.00 |
| December 31, 2011 | -0.00 |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.62M
Minimum
Dec 2021
--
Maximum
Mar 2020
-6.374M
Average
-3.799M
Median
Mar 2023
Cash from Investing (Quarterly) Benchmarks
| PetVivo Holdings Inc | -0.1862M |
| Acurx Pharmaceuticals Inc | -- |
| Kezar Life Sciences Inc | 27.88M |
| Allakos Inc | 20.19M |
| RAPT Therapeutics Inc | 20.64M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.34M |
| Cash from Financing (Quarterly) | 40.71M |
| Free Cash Flow | -109.90M |
| Free Cash Flow Per Share (Quarterly) | -0.3886 |
| Free Cash Flow to Equity (Quarterly) | -31.69M |
| Free Cash Flow Yield | -2.41K% |